RPX Corporation (RPXC) Tops Q2 EPS by 5c
Get Alerts RPXC Hot Sheet
Join SI Premium – FREE
RPX Corporation (NASDAQ: RPXC) reported Q2 EPS of $0.18, $0.05 better than the analyst estimate of $0.13. Revenue for the quarter came in at $80.4 million versus the consensus estimate of $81.15 million.
For earnings history and earnings-related data on RPX Corporation (RPXC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nurix Therapeutics, Inc. (NRIX) Reports Q3 EPS of $4.73
- Cryo-Cell International, Inc. (CCEL) Tops Q3 EPS by 13c
- Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share